HomeInsightsStock Comparison

Paushak Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Paushak Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Last Updated on: Mar 24, 2026

Key Highlights

  • The Latest Trading Price of Paushak Ltd is ₹ 396.5 as of 24 Mar 14:22 . The P/E Ratio of Paushak Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of Paushak Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of Paushak Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Paushak Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Paushak Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of Paushak Ltd changed from 4.95 % on March 2021 to 12.47 % on March 2025 . This represents a CAGR of 20.30% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About Paushak Ltd

  • Paushak Limited established in May, 1972, is part of the 'Alembic Group' having a legacy of more than 115 years.
  • Alembic Limited, the first company of Alembic Group, was established in 1907 in Vadodara, Gujarat, India and is the oldest Pharmaceutical Company in India. Paushak Limited is India's largest Phosgene based Specialty chemical manufacturer with core competencies in Isocyanates, Chloroformates, Carbamoyl Chlorides, Carbamates, Protecting agents etc.
  • Paushak si an India-based dealing in Speciality Chemicals Business. The Company is engaged in the production of phosgene gas and phosgene-based specialty chemicals/ intermediates.
  • Its products include isocyanates, chloroformates, carbamoyl chlorides, substituted urea, acid chlorides, carbonates, carbamates and others.
  • These chemicals are used in diverse fields, such as pesticides, pharmaceuticals, dyes, plastics and perfumeries.

About Tatva Chintan Pharma Chem Ltd

  • Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
  • The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
  • The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
  • The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of Paushak Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, Paushak Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of Paushak Ltd is 919 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,619 Cr

What are the key factors driving the stock performance of Paushak Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of Paushak Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Paushak Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 24, 2026, the Paushak Ltd stock price is INR ₹373.05. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1119.65.

How do dividend payouts of Paushak Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of Paushak Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions